Results 21 to 30 of about 168,140 (338)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.
Journal of Clinical Oncology, 2020 PURPOSE
Preoperative chemoradiotherapy may improve the radical resection rate for resectable or borderline resectable pancreatic cancer, but the overall benefit is unproven.E. Versteijne, M. Suker, Karin B. C. Groothuis, J. M. Akkermans-Vogelaar, M. Besselink, B. Bonsing, J. Buijsen, O. Busch, G. Creemers, R. V. van Dam, F. Eskens, S. Festen, J. D. de Groot, B. Groot Koerkamp, I. D. de Hingh, M. Homs, J. V. van Hooft, E. D. Kerver, S. Luelmo, K. Neelis, J. Nuyttens, G. Paardekooper, G. Patijn, M. V. D. van der Sangen, J. de Vos-Geelen, J. Wilmink, A. Zwinderman, C. Punt, C. V. van Eijck, G. van Tienhoven +29 moresemanticscholar +1 more sourceInduction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions. [PDF]
, 2018 BackgroundThe value of induction chemotherapy (ICT) remains under investigation despite decades of research. New advancements in the field, specifically regarding the induction regimen of choice, have reignited interest in this approach for patients with Cohen, EEW, Haddad, RI, Hitt, R, Lefebvre, J-L, Posner, M, Schulten, J, Vermorken, JB +6 morecore +1 more sourcePreoperative versus postoperative chemoradiotherapy for rectal cancer.
New England Journal of Medicine, 2004 BACKGROUND
Postoperative chemoradiotherapy is the recommended standard therapy for patients with locally advanced rectal cancer. In recent years, encouraging results with preoperative radiotherapy have been reported.R. Sauer, H. Becker, W. Hohenberger, C. Rödel, C. Wittekind, R. Fietkau, P. Martus, J. Tschmelitsch, E. Hager, C. Hess, J. Karstens, T. Liersch, H. Schmidberger, R. Raab +13 moresemanticscholar +1 more sourceThe Neo-PLANET phase II trial of neoadjuvant camrelizumab plus concurrent chemoradiotherapy in locally advanced adenocarcinoma of stomach or gastroesophageal junction
Nature Communications, 2022 The synergistic effect of neoadjuvant immunotherapy and chemoradiotherapy in gastric adenocarcinoma is unclear. This phase II trial (NCT03631615) investigated this neoadjuvant combination in locally advanced adenocarcinoma of stomach or gastroesophageal ...Zhaoqing Tang, Yan Wang, Dan Liu, Xuefei Wang, Chen Xu, Yiyi Yu, Yuehong Cui, Cheng Tang, Qian Li, Jing Sun, Qian Zhang, Yuan Ji, Guifen Ma, Haojie Li, Zhenbin Shen, K. Shen, Rongrong Zheng, Z. Hou, Tianshu Liu, Jiping Wang, Yihong Sun +20 moresemanticscholar +1 more sourceInterventions for the treatment of oral cavity and oropharyngeal cancer:chemotherapy [PDF]
, 2010 <b>Background:</b> Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally surgery followed by radiotherapy, whereas oropharyngeal Abdel Wahab, Abele, Adelstein, Adelstein, Adelstein, Andreadis, Andres, Anonymous, Anonymous, Ansfield, Arcangeli, Aref, Attner, Bachaud, Bakowski, Bensadoun, Berger, Bernier, Bernier, Bezwoda, Biakhov, Biakhov, Bitter, Bitter, Blasio, Boidi, Bolla, Bonner, Bourhis, Bourhis, Bradley, Brigham, Brizel, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Brunin, Brunin, Budach, Budach, Buentzel, Buentzel, Buntzel, Buntzel, Buntzel, Buntzel, Cachin, Calais, Calais, Calais, Calais, Calais, Calais, Caponigro, Caponigro, Cappelaere, Cappelaere, Carugati, Chassagne, Chauvergne, Chauvergne, Clavel, Clifford, Coates, Coninx, Coninx, Conway, Cooper, Corey, Corvo, Corvo, Corvo, Crispino, Cruz, Cummings, Dalley, Datta, Day, DeConti, Denis, Denis, Depondt, Dobrowsky, Dobrowsky, Domenge, Domenge, Domenge, Domenge, Ebeling, Eschwege, Eschwege, Ezra, Faggiano, Fakhry, Fanucchi, Fazekas, Fazekas, Fety, Fety, Fonseca, Forastiere, Fountzilas, Fountzilas, Fu, Fu, Fujii, Fujii, Funk, Furukawa, Gabriele, Gasparini, Gedouin, Gedouin, Gehanno, Gibson, Gladkov, Gollin, Gonzalez-Larriba, Grandi, Grau, Grau, Grau, Griem, Gupta, Gupta, Haas, Haas, Haas, Haddad, Haddadin, Haffty, Haffty, Haffty, Haffty, Haffty, Hafty, Handa, Harari, Hasegawa, Haselow, Henk, Heyden, Heyden, Heyden, Heyden, Heyden, Heyden, Hitt, Holoye, Holoye, Homma, Hong, Hughes, Huguenin, Hussey, Jacobs, Jain, Jaulerry, Jeremic, Jeremic, Jeremic, Jeremic, Jeremic, Jones, Jortay, Kaneda, Kapstad, Kapstad, Katori, Keegan, Knowlton, Kotani, Kramer, Krishnamurthi, Kumar, Laccourreye, Lam, Laramore, Lavertu, Le, Le, Lee, Lewin, Licitra, Lim, Lippman, Lo, Lopes, Luboinski, Macfarlane, Magno, Maipang, Mantovani, Marechal, Martin, Martin, Martin, Mazeron, McGurk, Mechl, Merlano, Merlano, Merlano, Merlano, Merlano, Merlano, Mohr, Monson, Morita, Morton, Morton, Nervi, Nissenbaum, O'Connor, Olasz, Olasz, Oliver, Oliver, Olmi, Olmi, Paccagnella, Paccagnella, Panis, Papac, Parkin, Parmar, Partridge, Parvinen, Patel, Pavitt, Pearlman, Pentenero, Petrovich, Petrovich, Phillips, Pignon, Pinnaro, Pinto, Platzer, Posner, Price, Prévost, Racadot, Rao, Rao, Rapoport, Rasch, Rasch, Rentschler, Richard, Richard, Richard, Richard, Rischin, Rischin, Rischin, Rodrigo, Ruo Redda, Ryerson, Salvajoli, Sanchiz, Sanguineti, Schildhauer, Schildhauer, Schroder, Schuller, Schuller, Schuller, Sealy, Segura, Semrau, Shah, Shanta, Shaw, Shetty, Siodlak, Smid, Smid, Soo, Specenier, Staar, Staar, Stefani, Stefani, Stell, Stell, Sturgis, Suwinski, Szabo, Szpirglas, Szpirglas, Szpirglas, Taylor, Taylor, Taylor, Tejedor, Tepmongkol, Tobias, Tobias, Tobias, Tobias, Toohill, Toohill, Tsukuda, Tsukuda, Valverde, Vecchia, Vega, Vermund, Veronesi, Volling, Volling, Volling, Weissberg, Weissberg, Weissberg, Weissberg, Weissberg, Weissler, Wendt, Wendt, WHO, Woods, Woods, Woods, Woolgar, Yoshino, Yoshino, Zakotnik, Zakotnik, Zakotnik, Zorat, Zorat +337 morecore +6 more sourcesNimotuzumab combined with chemoradiotherapy for the treatment of cervical cancer: A meta-analysis of randomized controlled trials
Frontiers in Oncology, 2022 ObjectivesTo assess the clinical efficacy and toxicity of nimotuzumab in combination with chemoradiotherapy or chemoradiotherapy alone in the treatment of cervical cancer.MethodsThe PubMed, Embase, Cochrane Library, Web of Science, China National ...Yan Yuan, Yan Yuan, Jiuzhou Chen, Jiuzhou Chen, Miao Fang, Miao Fang, Yaru Guo, Yaru Guo, Xueqing Sun, Xueqing Sun, Dehong Yu, Yilong Guo, Yong Xin, Yong Xin +13 moredoaj +1 more sourceClinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer [PDF]
, 2017 . Background: To evaluate the treatment tolerance
and clinical outcomes in patients aged 70 years and older with
locally advanced oropharyngeal cancer treated by definitive
intensity-modulated radiation therapy (IMRT).Benevento, Ilaria, Bulzonetti, Nadia, Caiazzo, Rossella, DE FELICE, Francesca, Magnante, ANNA LISA, Musio, Daniela, Tombolini, Vincenzo +6 morecore +1 more sourceClinical predictive factors of pathologic complete response in locally advanced rectal cancer [PDF]
, 2016 Background: Predictive factors of pathologic complete response (pCR) after neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) are still not identified. The purpose of this study was to define them.
Materials and Methods: Data Bulzonetti, Nadia, DE FELICE, Francesca, DI CELLO, Pierfrancesco, Izzo, Luciano, Izzo, Paolo, Izzo, Sara, Lucchetti, Pietro, Magnante Anna, Lisa, Musio, Daniela, Pugliese, Federico, Tombolini, Vincenzo +10 morecore +1 more source
